Drugs / Methylprednisolone
last change 8 days ago re-read 8 days ago

Methylprednisolone

Other / unclassified targets AQP2

Developed for
COVID-19 · lymphoma · osteoarthritis, knee · acute graft versus host disease · chronic lymphocytic leukemia/small lymphocytic lymphoma · leukemia · multiple sclerosis · myelodysplastic syndrome
+268 more · acute respiratory distress syndrome · cardiac arrest · ischemic stroke · plasma cell myeloma · acute myocarditis · drug-induced liver injury · hemophagocytic syndrome · idiopathic pulmonary fibrosis · optic neuritis · pneumocystosis · pneumonia · radiculopathy · relapsing-remitting multiple sclerosis · rheumatoid arthritis · adult acute respiratory distress syndrome · arthropathy · cancer · chronic pain syndrome · congenital heart disease · disease of orbital part of eye adnexa · HIV infectious disease · lumbar spinal stenosis · migraine disorder · osteoarthritis · osteoarthritis, hand · secondary hemophagocytic lymphohistiocytosis · systemic lupus erythematosus · ulcerative colitis · acquired hemophagocytic lymphohistiocytosis associated with malignant disease · acute lymphoblastic leukemia · acute respiratory failure · autoimmune hepatitis · B-cell chronic lymphocytic leukemia · bacterial pneumonia · bursitis · carpal tunnel syndrome · chronic obstructive pulmonary disease · chronic rhinosinusitis · cirrhosis of liver · cluster headache syndrome · endocrine exophthalmos · epicondylitis · facial paralysis · frozen shoulder · Hodgkins lymphoma · IgA glomerulonephritis · immunodeficiency disease · immunoglobulin A vasculitis · impacted teeth, multiple · intracerebral hemorrhage · ischemic disease · Kawasaki disease · lumbar disk disease · membranous glomerulonephritis · microscopic polyangiitis · multiple organ dysfunction syndrome · peripheral T-cell lymphoma, not otherwise specified · plasma cell neoplasm · rotator cuff syndrome · severe acute respiratory syndrome · sudden sensorineural hearing loss · viral pneumonia · acoustic neuroma · acute lung injury · acute transplant rejection · adenoviridae infectious disease · adrenocortical insufficiency · ALK-negative anaplastic large cell lymphoma · anaplastic large cell lymphoma · angioimmunoblastic T-cell lymphoma · ankylosing spondylitis · anti-neutrophil cytoplasmic antibody-associated vasculitis · aortic valve stenosis · aplastic anemia · appendicitis · atrial fibrillation · atrioventricular block · autoimmune encephalitis · autoimmune thrombocytopenic purpura · B-cell acute lymphoblastic leukemia · B-cell adult acute lymphocytic leukemia · B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2) · biliary atresia · brain infarction · bronchiolitis · bronchopulmonary dysplasia · Burkitt lymphoma · cardiac rhythm disease · cardiogenic shock · cerebral artery occlusion · cerebral infarction · cervical lymphadenitis · chemical colitis · childhood acute lymphoblastic leukemia · cholangitis · cholestasis · chronic graft versus host disease · chronic hepatitis B virus infection · chronic progressive multiple sclerosis · chronic renal failure syndrome · classic Hodgkin lymphoma · cognitive disorder · colitis · cranial nerve neuropathy · Crohn disease · cytokine release syndrome · disease of bone structure · disease of the tendon · disease related to solid organ transplantation · drug rash with eosinophilia and systemic symptoms · encephalomalacia · end stage renal failure · enteropathy-associated T-cell lymphoma · eosinophilic granulomatosis with polyangiitis · epilepsy · epiphora due to insufficient drainage · Epstein-Barr virus infection · erythema multiforme · esophagitis · extranodal nasal NK/T cell lymphoma · facial nerve disorder · Fanconi anemia · Friedreich ataxia · giant cell myocarditis · granulomatosis with polyangiitis · granulomatous mastitis · Guillain-Barre syndrome · heart failure · hemangioma · hepatosplenic T-cell lymphoma · HIV-associated cancer · idiopathic membranous glomerulonephritis · immune reconstitution inflammatory syndrome · indeterminate colitis · infantile spasms · infectious disease · infectious disease with sepsis · inflammatory bowel disease · inflammatory disease · influenza · interstitial lung disease · intussusception · juvenile idiopathic arthritis · kidney disorder · language disorder · laryngostenosis · lung disorder · lupus nephritis · lymphopenia · macrophage activation syndrome · Meniere disease · metastatic malignant neoplasm in the brain · mixed phenotype acute leukemia · mouth mucosa disorder · Mycoplasma pneumoniae pneumonia · myelodysplastic/myeloproliferative disease · myopathy · nasal cavity polyp · nervous system injury · neuroendocrine cell hyperplasia of infancy · neuromyelitis optica · neuropathy, painful · noise induced hearing loss · non-amyloid fibrillary glomerulopathy · oligoarticular juvenile idiopathic arthritis · ornithosis · ovarian hyperstimulation syndrome · palmar fibromatosis · paraneoplastic sensory ganglionopathy · pauci-immune glomerulonephritis with ANCA · pediatric arterial ischemic stroke · platinum-induced ototoxicity · pneumonitis · polyarteritis nodosa · post-surgical hypoinsulinemia · post-transplant lymphoproliferative disease · primary biliary cholangitis · primary central nervous system lymphoma · psoriatic arthritis · pulpitis · radial heads, posterior dislocation of · radiation-induced disorder · restless legs syndrome · rheumatic fever · rheumatic heart disease · rheumatoid factor-negative juvenile idiopathic arthritis · Richter transformation · sarcoidosis · sciatica · shoulder impingement syndrome · sickle cell disease · sleep disorder · spinal cord injury · spinal stenosis · subarachnoid hemorrhage · T-cell acute lymphoblastic leukemia · T-cell adult acute lymphocytic leukemia · tenosynovitis · thymoma · thyrotoxic exophthalmos · traumatic brain injury · type 2 diabetes mellitus · urinary tract infection · vestibular disorder · viral encephalitis · abdominal aortic aneurysm · abdominal wall malformation · acute kidney injury · acute liver failure · alcoholic hepatitis · alopecia areata · alopecia totalis · alopecia universalis · arthritis, sacroiliac · asthma · atherosclerosis · autoimmune thrombocytopenia · autoinflammatory syndrome · Behcet disease · calcific tendinitis · cerebrovascular disorder · chondrocalcinosis · COVID-19–associated multisystem inflammatory syndrome in children · delirium · diabetes mellitus · disorder of facial skeleton · drug-induced hepatitis · dysphagia lusoria · enthesopathy · esophageal disorder · ganglion or cyst of synovium/tendon/bursa · gout · hantavirus infectious disease · heart disorder · keloid · keloid formation · liver disorder · lumbar disk degenerative disorder · Morton neuroma · muscular atrophy · musculoskeletal system disorder · neuralgia · neurogenic arthropathy · non-arteritic anterior ischemic optic neuropathy · ocular tuberculosis · optic nerve disorder · pediatric acute respiratory distress syndrome · plantar fasciitis · post-cardiac arrest syndrome · post-COVID-19 disorder · radiculitis · seasonal allergic rhinitis · secondary progressive multiple sclerosis · sensorineural hearing loss disorder · sinusitis · spondyloarthropathy · spondylosis · ST-elevation myocardial infarction · stroke disorder · sudden hearing loss disorder · suppurative periapical periodontitis · systemic sclerosis · temporomandibular joint disorder · tendinosis · tendon sheath disorder · toxic optic neuropathy · vasculitis · vestibular neuronitis
Investigated by
National Cancer Institute (NCI) · Assistance Publique - Hôpitaux de Paris · Beijing Friendship Hospital · M.D. Anderson Cancer Center · Qingyuan Zhan · Beijing Tiantan Hospital
+457 more · Emory University · Mayo Clinic · National Institute of Allergy and Infectious Diseases (NIAID) · Shengjing Hospital · Assiut University · Beijing Tongren Hospital · Incyte Corporation · Masonic Cancer Center, University of Minnesota · National Taiwan University Hospital · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Yale University · Biogen · Daihong Liu · Fred Hutchinson Cancer Center · Massachusetts General Hospital · National Heart, Lung, and Blood Institute (NHLBI) · Pfizer · Sun Yat-sen University · The First Affiliated Hospital of Guangzhou Medical University · University of Athens · University of California, San Diego · ZonMw: The Netherlands Organisation for Health Research and Development · Bayer · Beijing 302 Hospital · Beijing Children's Hospital · Centre Hospitalier Universitaire Dijon · Charite University, Berlin, Germany · Children's Hospital of Fudan University · Children's Oncology Group · Chinese PLA General Hospital · Dana-Farber Cancer Institute · Department of Anesthesiology Faculty Development Fund · EPC Education s.r.o. · Fondazione IRCCS Policlinico San Matteo di Pavia · French Innovative Leukemia Organisation · Genentech, Inc. · Guangdong Provincial People's Hospital · Gyeongsang National University Hospital · H. Lee Moffitt Cancer Center and Research Institute · Hospital for Special Surgery, New York · Leiden University Medical Center · Medical Research Council · Medical University of South Carolina · National Cancer Center, Korea · National Center for Advancing Translational Sciences (NCATS) · National Cheng-Kung University Hospital · National Eye Institute (NEI) · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · National Institute of Neurological Disorders and Stroke (NINDS) · Niguarda Hospital · Northwestern University · Oncotherapeutics · Qilu Hospital of Shandong University · Rennes University Hospital · Rigshospitalet, Denmark · Samsung Medical Center · Second Affiliated Hospital, School of Medicine, Zhejiang University · Shenzhen People's Hospital · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Sohag University · Stanford University · Tang-Du Hospital · Tanta University · The Hospital for Sick Children · The Physicians' Services Incorporated Foundation · Third Affiliated Hospital, Sun Yat-Sen University · Tongji Hospital · Universitaire Ziekenhuizen KU Leuven · University Hospital, Ghent · University of Alabama at Birmingham · University of Colorado, Denver · University of Southern California · University of Thessaly · all 463 on the full record

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) MEDROL — 1957-10-24 fda.gov ↗

Trials 390 · started per year

today
US approved 1957
2
1
1
1
3
3
1
5
2
1
3
2
3
5
6
12
7
5
9
9
9
16
14
14
8
11
12
12
15
20
30
29
25
21
17
29
26
195619571958195919601961196219631964196519661967196819691970197119721973197419751976197719781979198019811982198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027202820292030
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 010 trials
Phase 0 NCT07803978 May 2026 → May 2029 expected acute graft versus host disease Chinese PLA General Hospital Enrolling by invitation No outcome recorded
Phase 0 NCT07081399 Aug 2024 → Mar 2025 overdue — Damanhour University Recruiting No outcome recorded
Phase 0 NCT06453083 Jan 2023 → Dec 2024 — University of Utah Completed No outcome recorded
Phase 0 NCT06209606 Dec 2022 → May 2026 overdue plasma cell myeloma Oncotherapeutics Recruiting No outcome recorded
Phase 0 NCT05532072 Sep 2022 → Sep 2023 disease of orbital part of eye adnexa First Affiliated Hospital Xi'an Jiaotong University Unknown No outcome recorded
Phase 0 NCT04988256 Sep 2021 → Apr 2026 overdue drug rash with eosinophilia and systemic symptoms University of Southern California Enrolling by invitation No outcome recorded
Phase 0 NCT05317624 Aug 2021 → Nov 2022 arthropathy Alexandria University Completed No outcome recorded
Phase 0 NCT06185426 Jan 2021 → Jun 2023 facial nerve disorder, nervous system injury Recep Tayyip Erdogan University Unknown No outcome recorded
Phase 0 NCT04233164 Mar 2020 → May 2022 systemic lupus erythematosus National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Completed No outcome recorded
Phase 0 NCT02424435 Jun 2015 → Dec 2017 Friedreich ataxia Children's Hospital of Philadelphia Completed No outcome recorded
Phase 113 trials
Phase 1 NCT07070882 Jun → Dec 2025 overdue osteoarthritis, knee Columbia University Active not recruiting No outcome recorded
Phase 1 NCT07576010 Jan 2025 → Dec 2027 expected acute graft versus host disease Daihong Liu Active not recruiting No outcome recorded
Phase 1 NCT06462781 Mar 2024 → May 2025 migraine disorder The Cooper Health System Completed No outcome recorded
Phase 1 NCT05587673 Oct 2022 → Oct 2023 Crohn disease, indeterminate colitis, ulcerative colitis Stanford University Completed No outcome recorded
Phase 1 NCT05280873 Oct 2021 → Oct 2023 cancer, pneumonitis Zhou Chengzhi Unknown No outcome recorded
Phase 1 NCT04981912 Sep 2021 → Jul 2025 overdue chronic lymphocytic leukemia/small lymphocytic lymphoma University of California, San Diego Active not recruiting No outcome recorded
Phase 1 NCT04509219 Apr 2020 → Apr 2021 Kawasaki disease Chang Gung Memorial Hospital Unknown No outcome recorded
Phase 1 NCT05655130 Nov 2018 → May 2023 disease of bone structure, radial heads, posterior dislocation of Indiana Hand to Shoulder Center Terminated No outcome recorded
Phase 1 NCT03113695 Dec 2017 → May 2022 Richter transformation, chronic lymphocytic leukemia/small lymphocytic lymphoma University of California, San Diego Completed No outcome recorded
Phase 1 NCT03110822 Feb 2017 → Sep 2024 overdue plasma cell myeloma Oncotherapeutics Recruiting No outcome recorded
Phase 1/218 trials · 2 met primary
Phase 1/2 NCT07525466 Apr 2026 → Mar 2028 expected extranodal nasal NK/T cell lymphoma, secondary hemophagocytic lymphohistiocytosis Beijing Tongren Hospital Recruiting No outcome recorded
Phase 1/2 NCT07357935 Feb 2026 → Sep 2028 expected acute respiratory failure, bacterial pneumonia Qingyuan Zhan Not yet recruiting No outcome recorded
Phase 1/2 NCT06809998 Jan 2025 → Aug 2026 overdue osteoarthritis, knee Unity Health Toronto Recruiting No outcome recorded
Phase 1/2 NCT05123040 Jun 2023 → Feb 2026 acute graft versus host disease Masonic Cancer Center, University of Minnesota Terminated No outcome recorded Stop: Business
Phase 1/2 NCT05476679 Sep 2022 → Jun 2023 — Raziel Therapeutics Ltd. Completed No outcome recorded
Phase 1/2 NCT04219995 Feb 2020 → Feb 2021 epilepsy Louisiana State University Health Sciences Center in New Orleans Unknown No outcome recorded
Phase 1/2 NCT05640375 Dec 2019 → Dec 2023 intussusception Baskent University Completed Met primary
Phase 1/2 NCT04151082 Oct 2019 → Jul 2027 expected cranial nerve neuropathy, oropharyngeal carcinoma M.D. Anderson Cancer Center Recruiting No outcome recorded
Phase 1/2 NCT02049073 Oct → Nov 2017 noise induced hearing loss Washington University School of Medicine Withdrawn No outcome recorded
Phase 1/2 NCT03266146 Sep 2017 → Jan 2023 drug-induced liver injury Beijing 302 Hospital Completed No outcome recorded
Phase 283 trials · 3 met primary · 4 missed
Phase 2 NCT07461961 Jul 2026 → Feb 2028 expected cardiogenic shock, heart failure Brigham and Women's Hospital Not yet recruiting No outcome recorded
Phase 2 NCT07054801 Jun 2026 → Jan 2027 expected subarachnoid hemorrhage Daniel Raper, MBBS Recruiting No outcome recorded
Phase 2 NCT07511582 Apr 2026 → Apr 2028 expected adult acute respiratory distress syndrome, infectious disease with sepsis Bin Du Recruiting No outcome recorded
Phase 2 NCT07516522 Mar 2026 → Dec 2027 expected cerebral artery occlusion, ischemic stroke Tang-Du Hospital Recruiting No outcome recorded
Phase 2 NCT06841705 Jul 2025 → Jul 2026 overdue — Shilpa Grover, MD, MPH Recruiting No outcome recorded
Phase 2 NCT06471556 Jun 2025 → Feb 2029 expected neuroendocrine cell hyperplasia of infancy Assistance Publique - Hôpitaux de Paris Recruiting No outcome recorded
Phase 2 NCT07509749 Jun 2025 → Dec 2027 expected acute graft versus host disease Daihong Liu Recruiting No outcome recorded
Phase 2 NCT07340723 Jun 2025 → Jun 2027 expected acute graft versus host disease Daihong Liu Recruiting No outcome recorded
Phase 2 NCT06936566 May 2025 → Jun 2027 expected acute graft versus host disease John Levine Recruiting No outcome recorded
Phase 2 NCT06896253 Apr 2025 → May 2029 expected acute myocarditis Assistance Publique - Hôpitaux de Paris Not yet recruiting No outcome recorded
Phase 2/319 trials · 1 met primary · 3 missed
Phase 2/3 NCT07542288 Apr 2026 → Jun 2028 expected metastatic malignant neoplasm in the brain The Second Affiliated Hospital of Hainan Medical University Not yet recruiting No outcome recorded
Phase 2/3 NCT07152587 Sep 2025 → Dec 2035 expected infectious disease Qingyuan Zhan Not yet recruiting No outcome recorded
Phase 2/3 NCT07151417 Sep 2025 → Aug 2026 overdue osteoarthritis, knee Walter Reed National Military Medical Center Not yet recruiting No outcome recorded
Phase 2/3 NCT06496997 Aug 2024 → Apr 2025 acute respiratory distress syndrome Fayoum University Completed No outcome recorded
Phase 2/3 NCT05752305 Jan 2022 → Jul 2023 — University of Granada Completed No outcome recorded
Phase 2/3 NCT05003596 Sep 2021 → Aug 2022 — Robert Wood Johnson Barnabas Health Unknown No outcome recorded
Phase 2/3 NCT04942002 Jun 2021 → Jun 2023 optic neuritis Asociación para Evitar la Ceguera en México Unknown No outcome recorded
Phase 2/3 NCT04349410 Apr → Sep 2020 COVID-19 The Camelot Foundation Completed No outcome recorded
Phase 2/3 NCT04244591 Jan → Apr 2020 COVID-19 Peking Union Medical College Hospital Completed No outcome recorded
Phase 2/3 NCT04693312 Jan → Mar 2020 chronic pain syndrome Assiut University Completed No outcome recorded
Phase 391 trials · 5 met primary · 11 missed
Phase 3 NCT07830108 Dec 2026 → Dec 2034 expected rheumatic fever, rheumatic heart disease Starship Child Health, Te Toka Tumai Auckland Not yet recruiting No outcome recorded
Phase 3 NCT07650396 Jun 2026 → Dec 2027 expected disease of the tendon Erasmus Medical Center Recruiting No outcome recorded
Phase 3 NCT07507643 Mar 2026 → Mar 2029 expected — Memorial Sloan Kettering Cancer Center Recruiting No outcome recorded
Phase 3 NCT06474273 Mar 2026 → Jun 2030 expected acute transplant rejection University of Sydney Recruiting No outcome recorded
Phase 3 NCT07152600 Feb 2026 → Jun 2027 expected adenoviridae infectious disease Qingyuan Zhan Not yet recruiting No outcome recorded
Phase 3 NCT07351500 Jan 2026 → Nov 2028 expected influenza Qingyuan Zhan Not yet recruiting No outcome recorded
Phase 3 NCT07352865 Jan 2026 → Nov 2028 expected ornithosis Qingyuan Zhan Not yet recruiting No outcome recorded
Phase 3 NCT07371572 Oct 2025 → Apr 2028 expected osteoarthritis, hand Sint Maartenskliniek Recruiting No outcome recorded
Phase 3 NCT07152613 Sep 2025 → Jun 2027 expected pneumocystosis Qingyuan Zhan Not yet recruiting No outcome recorded
Phase 3 NCT07202143 Sep 2025 → Sep 2026 overdue brain infarction, lymphopenia YiLin Recruiting No outcome recorded
Phase 488 trials · 2 met primary · 8 missed
Phase 4 NCT07497737 Dec 2026 → Apr 2027 expected frozen shoulder University Hospitals Cleveland Medical Center Not yet recruiting No outcome recorded
Phase 4 NCT07703098 Sep 2026 → Sep 2029 expected adrenocortical insufficiency University Medical Centre Ljubljana Not yet recruiting No outcome recorded
Phase 4 NCT07605923 Sep 2026 → Aug 2031 expected — University of Alabama at Birmingham Not yet recruiting No outcome recorded
Phase 4 NCT07245732 Apr 2026 → Mar 2029 expected rheumatoid arthritis Sunnybrook Health Sciences Centre Recruiting No outcome recorded
Phase 4 NCT07180277 Mar 2026 → Jan 2029 expected traumatic brain injury Zhangjiagang First People's Hospital Recruiting No outcome recorded
Phase 4 NCT07353749 Jan 2026 → Aug 2027 expected brain aneurysm, hemorrhagic stroke Duan Chuanzhi Not yet recruiting No outcome recorded
Phase 4 NCT06483204 Jan 2026 → Jan 2027 nasal disorder Vanderbilt University Medical Center Withdrawn No outcome recorded
Phase 4 NCT06489626 Nov 2025 → Oct 2027 osteoarthritis, knee F. Johannes Plate Withdrawn No outcome recorded
Phase 4 NCT07101445 Sep 2025 → Dec 2026 expected plasma cell myeloma Emory University Recruiting No outcome recorded
Phase 4 NCT06924983 May 2025 → Nov 2026 expected intracerebral hemorrhage Yong Jiang Not yet recruiting No outcome recorded
Phase not applicable68 trials · 1 met primary · 6 missed
— NCT07804199 Sep 2026 → Jan 2028 expected osteoarthritis, knee VA Office of Research and Development Recruiting No outcome recorded
— NCT07792473 Sep 2026 → Feb 2027 expected mouth mucosa disorder University of Yalova Not yet recruiting No outcome recorded
— NCT07512648 Mar 2026 → Apr 2028 expected breast disorder, granulomatous mastitis Caigang Liu Not yet recruiting No outcome recorded
— NCT07328906 Jan 2026 → Jan 2027 expected — University of Belgrade Not yet recruiting No outcome recorded
— NCT07175649 Oct 2025 → Dec 2028 expected ischemic stroke Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Not yet recruiting No outcome recorded
— NCT07175623 Sep → Dec 2025 curariform drugs toxicity Konya City Hospital Completed No outcome recorded
— NCT06922669 Jun 2025 → Mar 2027 expected drug-induced liver injury General Hospital of Shenyang Military Region Recruiting No outcome recorded
— NCT06693856 Jan 2025 → Jun 2026 overdue disease of orbital part of eye adnexa Zou Junjie Enrolling by invitation No outcome recorded
— NCT06203847 Jul 2024 → Jul 2026 overdue cardiac arrest National Taiwan University Hospital Recruiting No outcome recorded
— NCT06631976 Jun 2024 → May 2026 overdue rotator cuff syndrome, sleep disorder Medical University of Lodz Recruiting No outcome recorded
Comparator or background therapy640 trials
Phase 0 NCT07519005 Background Jan → Feb 2026 overdue liver failure Xijing Hospital Active not recruiting No outcome recorded
Phase 0 NCT06081101 Comparator Mar 2025 → Jul 2028 expected arthritis, sacroiliac McMaster University Recruiting No outcome recorded
Phase 0 NCT06707389 Comparator Dec 2024 → Jun 2026 overdue sensorineural hearing loss disorder, sudden hearing loss disorder Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Not yet recruiting No outcome recorded
Phase 0 NCT06119490 Background Jul 2023 → Jul 2026 overdue toxic epidermal necrolysis Peng Zhang Recruiting No outcome recorded
Phase 0 NCT05742061 Comparator Apr → Oct 2023 osteoarthritis, knee Benha University Unknown No outcome recorded
Show all 640 trials opens the full record — a long page

News releases announcing trial results or a regulatory action · 4

DateIssuerRelease
2021-01-21 Oncotherapeutics Results Efficacy and Safety of Ruxolitinib and Steroids for Treating Patients with Relapsed or Refractory Multiple Myeloma (RRMM). Results from the I-RUX Study Published in ASH2020 oncotherapeutics.com ↗
Of the 17 evaluable patients treated with RUX and steroids so far, the CBR and ORR were 53% (n=8) and 33% (n=5), respectively.
2019-02-25 Lupin Limited Regulatory Lupin receives FDA approval for Methylprednisolone Tablets USP lupin.com ↗
Mumbai, Baltimore: Pharma major Lupin announced that it has received approval for its Methylprednisolone Tablets USP, 2 mg, 4 mg, 8 mg, 16 mg and 32 mg, from the United States Food and Drug Administration (FDA) to market a generic version of Pharmacia and Upjohn Company’s Medrol tablets, 2 mg, 4 mg, 8 mg, 16 mg and 32 mg.
2018-04-25 Zydus Lifesciences Limited Regulatory Zydus receives final approval from the USFDA for Methylprednisolone Tablets USP and Cinacalcet Hydrochloride Tablets zyduslife.com ↗
2005-02-24 Teva Branded Pharmaceutical Products R&D, Inc. Regulatory Teva Announces Approval Of Methylprednisolone Acetate Injectable Suspension tevapharm.com ↗
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that the U.S. Food and Drug Administration has granted final approval for the Company's ANDA for Methylprednisolone Acetate Injectable Suspension, 40 mg/mL and 80 mg/mL in single dose vials.

Evidence & citations 39 cited values

Every value below carries the sentence it was read from. 1,036 sources stand behind the page.

FieldValueCited text
Known as methylprednisolone “including but not limited to DHAP (dexamethasone, cisplatin, high-dose cytarabine), ESHAP (etoposide, methylprednisolone, high-dose cytarabine and cisplatin), DICE...” NCT04486391 ↗
911

“Intravenous methylprednisolone 1.6 mg/kg per day (given in 2 divided doses, with the maximum dose 60mg of prednisolone ) for 3 days, which is administered concurrently with the...” NCT04078568 ↗

“Oral methylprednisolone tablets (brand name: Metrol®), 20 mg once daily for 14 consecutive days; following symptom relief, the dose should be gradually reduced every 1-2 weeks...” NCT07512648 ↗

“Methylprednisolone sodium succinate for injection, United States Pharmacopeia grade (USP), sold as SOLU-MEDROL sterile powder by Pfizer, Inc, is an anti-inflammatory...” NCT04233164 ↗

“Methylprednisolone sodium succinate 80 mg powder dissolved in 100 mL of sodium chloride solution (intravenous infusion, once daily) from the day of surgery to day 3, followed...” NCT07116811 ↗

“Patients in the corticosteroid group were treated with intravenous pulsed-steroid therapy: methylprednisolone 500 mg daily intravenously for three consecutive days followed by...” NCT01621880 ↗

“Participants in this arm received postoperative analgesia with periarticular infiltration consisting of 100 mg bupivacaine, 40 mg methylprednisolone, 0.5 mg adrenaline and...” NCT07849517 ↗

“Subjects will receive the conventional steroid regimen with prednisolone or equivalent (with methylprednisolone): Day 1 to 5: 40 mg orally every 12 h; Day 6 to 10: 40 orally...” NCT03856229 ↗

“Patients will begin prednisone therapy at a dose selected by the investigator or the treating physician with oral prednisone 60mg or 1mg/kg (if weight less than 60kg) or...” NCT02169219 ↗

“high dose corticosteroid therapy (intravenous pulses of 7,5 to 15 mg/kg/day of methylprednisolone with an upper limit of 1000 mg/day for 3 days followed by oral prednisone at 1...” NCT04239196 ↗

“Chemotherapy is based upon regimes with well known effectiveness in Hodgkin lymphoma. (i.e. ABVD: doxorubicin, bleomycin, vinblastine and dacarbazine and ESHAP: Etoposide,...” NCT03500133 ↗

Show 901 more sources

Known as 6-methyl-prednisolone “0.25 mg/kg/d of 6-methyl-prednisolone (Steroids, Urbason, Methypred) until month 1” NCT02540395 ↗
2

NCT02540395 ↗

NCT00127985 ↗

Known as acetate methylprednisolone “The goal of this study was double, at first comparing the glycaemic profile in diabetic patients after a unique injection of 80 mg of acetate methylprednisolone either...” PMID 22185681 ↗ Dec 2011
Known as Danalone “Methylprednisolone (Danalone) 1mg/Kg/dose twice daily for 14 days followed by 1mg/Kg/dose in the morning once daily for 14 days” NCT01614977 ↗
Known as depo-medrol “Epidural steroid injectate will be 2cc of 1% lidocaine followed by 1-3 cc of 40 mg/cc Kenalog (i.e. 40-120 mg Kenalog) or an equivalent steroid medication (depo-medrol 60-120...” NCT01238536 ↗
40

“one injection of depo-medrol at the site of inflamed ligament attachment point (femoral condyle), combined with oral slow-acting symptomatic drugs (glucosamine 1500mg, atrodar...” NCT05971004 ↗

“Patients receiving the IA corticosteroid will be injected 3mL of 0.5% Bupivacaine and 2mL of 80mg Depo Medrol in a 10cc syringe, using an aseptic technique into the suprapatellar pouch.” NCT01923909 ↗

“Following this application, an 18-20 gauge epidural needle will be used to inject a solution containing 80 mg Depo-Medrol in 1 ml of 1% PF Lidocaine and 5ml of sterile PF saline” NCT03543033 ↗

“Prior to surgical closure, patients received 1 ml of either Depo-Medrol (DEPO) or saline (NODEPO) applied to a Gelfoam carrier at the surgical site.” PMID 29676673 ↗ Apr 2018

“Participants receive 1-3 ultrasound-guided peritendinous injections of Depo-Medrol (methylprednisolone acetate 40 mg) combined with lidocaine.” NCT07650396 ↗

“Single methylprednisolone acetate intraarticular injection (DEPO-MEDROL® pfizer 80 mg) mixed with 3cc of (xylocaine 2% concentration)” NCT04980105 ↗

“Application of 40mg Depomedrol (methylprednisolone acetate) suspension into the retropharyngeal space prior to incision closure” NCT03311425 ↗

“Application of 80mg Depomedrol (methylprednisolone acetate) suspension into the transforaminal space prior to incision closure” NCT03308084 ↗

“1 ml methylprednisolon corticosteroid (40 mg Depo-Medrol®) mixed with 4 ml Lidocain (10 mg/ml) without adrenalin.” NCT01945749 ↗

“Dexamethasone 10mg or Depomedrol 40mg, together with Bupivacaine 0.25% (for 3-5mL total injectate volume)” NCT02103543 ↗

Show 30 more sources

Known as HDMP “All subjects will receive HDMP by IV infusion for up to 4 cycles (28-day cycles) as follow: •On Cycle 1-4, Days 1 to 3, 1,000 mg/m2 Methylprednisolone will be administered.” NCT02229422 ↗
2

“High dose methylprednisolone sodium succinate (HDMP) at 1gm/m2 daily as infusion for 3 consecutive days every cycle.” NCT01191190 ↗

“methylprednisolone 1000 mg/m2 (ie HDMP) on days 1-5 of cycles 1-4” NCT03113695 ↗

Known as High Volume injection with corticosteroid ClinicalTrials.gov intervention name — accepted as the source's own label NCT02839577 ↗
Known as IVMP “OBJECTIVE: To compare intravenous methylprednisolone (IVMP) with oral prednisolone (OP) for the treatment of West syndrome.” PMID 33575989 ↗ Feb 2021
8

“Participants randomised to the control arm will receive standard therapy of intravenous methylprednisolone (IVMP).” PMID 26009577 ↗ May 2015

“intravenous immunmoglobulin (IVIG), intravenous methylprednisolone (IVMP)” NCT03542279 ↗

“12 pulses of intravenous methylprednisolone (IVMP) in every week schedule” NCT03667157 ↗

“Intravenous injection of methylprednisolone (IVMP) for 14 days” NCT07410039 ↗

“Intravenous methylprednisolone (IVMP) 1000 mg daily for 3 days” NCT07420296 ↗

“Intravenous Methylprednisolone (IVMP)” NCT07184840 ↗

“methylprednisolone (IVMP)” NCT00934843 ↗

NCT07410039 ↗

Known as Medrol “Methylprednisolone(Common brand names: Medrol) or prednisone 20-40mg, qd for two weeks, then temper the dose gradually, and then 20mg qd for maintenance (The total duration of...” NCT03724903 ↗
11

“Methylprednisolone will be administered once a day either in tablets; Medrol 1g per day or iv; Solumedrol 1000 mg per day, both for three consecutive days.” NCT03674099 ↗

“Patients will receive 3 mg of methylprednisolone once daily. The dose is administered in the morning (1 ½ tablets of 2 mg Medrol after breakfast).” NCT07703098 ↗

“Therapeutic Interventions. Methylprednisolone (Medrol®) dose pack.” NCT03529929 ↗

“methylprednisolone - Medrol, 16mg Pfizer Laboratories” NCT05941130 ↗

“Medrol 4 MG Oral Tablet Includes Medrol Dosepak” NCT07158476 ↗

NCT05476679 ↗

NCT05480566 ↗

NCT02451748 ↗

NCT06483204 ↗

NCT00957801 ↗

Show 1 more source

Known as Medrol Dose Pack “Therapeutic Interventions. Methylprednisolone (Medrol®) dose pack.” NCT03529929 ↗
Known as Medrol Dosepak “Medrol 4 MG Oral Tablet Includes Medrol Dosepak” NCT07158476 ↗
Known as MEP “Single dose of MEP sodium succinate intravenously administered. MEP (equivalent to 62.5 mg of Methylprednisolone).” NCT05649878 ↗
Known as MEP sodium succinate “Single dose of MEP sodium succinate intravenously administered. MEP (equivalent to 62.5 mg of Methylprednisolone).” NCT05649878 ↗
Known as MePRDL “then intravenous methylprednisolone (MePRDL) tapered over the next 34 days” NCT00004785 ↗
4

“One group receives a 24-hour methylprednisolone (MePRDL) infusion:” NCT00004759 ↗

“Methylprednisolone, MePRDL, NSC-19987” NCT00002471 ↗

“MePRDL Methylprednisolone, NSC-19987” NCT00002599 ↗

“MePRDL Methylprednisolone succinate” NCT00002565 ↗

Known as Methylprednisolon “1 ml methylprednisolon corticosteroid (40 mg Depo-Medrol®) mixed with 4 ml Lidocain (10 mg/ml) without adrenalin.” NCT01945749 ↗
3

NCT05563571 ↗

NCT05851508 ↗

NCT02448316 ↗

Known as Methylprednisolone (Medrol) “Methylprednisolone (Medrol)” NCT01332617 ↗
1

“Methylprednisolone (Medrol)” NCT04438382 ↗

Known as Methylprednisolone (Solumedrol) “Methylprednisolone (Solumedrol)” NCT00296244 ↗
1

“Methylprednisolone, Solu-medrol” NCT01647685 ↗

Known as methylprednisolone acetate “Single injection into the glenohumeral joint under ultrasound guidance. Consists of 40 mg methylprednisolone acetate combined with 4 ml of 1% lidocaine hydrochloride. Delivered...” NCT06916650 ↗
44

“Patients were infiltrated with 2 milliliters of local corticosteroid (Methyl prednisolone acetate 80mg) mixed with 1 milliliters 0.5% Bupivacaine, at the lateral epicondyle...” NCT00947765 ↗

“Group l include 50 patients who will be injected with one intra\_articular injection of 2 ml of methylprednisolone acetate 40 mg/ml mixed with 2ml of lidocaine” NCT05742061 ↗

“Control Group (corticosteroid alone) subjects will receive (40 mg/mL injection of Methylprednisolone acetate injectable suspension or 40 mg/mL triamcinolone) .” NCT03704584 ↗

“Solution to be injected will be a combination of Ropivacaine 0.2 % ( 0.5 ml/kg, maximum of 30 ml) and methylprednisolone acetate 1 mg/kg ( maximum of 40 mg ).” NCT03053401 ↗

“Intra-articular injection consisting of 80 mg of methylprednisolone acetate, 2 mL of lidocaine (1%), and 4 mL of ropivacaine (0.5%)” NCT07497737 ↗

“Application of 40mg Depomedrol (methylprednisolone acetate) suspension into the retropharyngeal space prior to incision closure” NCT03311425 ↗

“This is 40mg of a non-fluorinated injectable glucocorticoid, methylprednisolone acetate (1cc) combined with 1cc of 1% Lidocaine” NCT02044991 ↗

“Application of 80mg Depomedrol (methylprednisolone acetate) suspension into the transforaminal space prior to incision closure” NCT03308084 ↗

“Participants in the CS category were given 1 ml of 40 mg methylprednisolone acetate mixed with 2 ml of 2% prilocaine HCl.” PMID 38963583 ↗ Jul 2024

“Methylprednisolone acetate (MPA)(Depomedrol) is a lipophilic glucocorticoid commonly used in chronic pain procedures.” NCT05893771 ↗

Show 34 more sources

Known as methylprednisolone acetate (Depo-Medrol) “methylprednisolone acetate (Depo-Medrol)” NCT04438382 ↗
Known as methylprednisolone sodium succinate “Methylprednisolone sodium succinate for injection, United States Pharmacopeia grade (USP), sold as SOLU-MEDROL sterile powder by Pfizer, Inc, is an anti-inflammatory...” NCT04233164 ↗
26

“Methylprednisolone sodium succinate is a synthetic glucocorticoid (corticosteroid) administered intravenously at a single dose of 125 mg one hour prior to the surgical...” NCT07317596 ↗

“The study determined if the administration of the corticosteroid, methylprednisolone sodium succinate, in severe ARDS that was either stable or worsening after 7 days, would...” NCT00000579 ↗

“Methylprednisolone sodium succinate can reduce the disruption of the blood-brain barrier and inflammatory response in animal models of intracerebral hemorrhage, and alleviate...” NCT06924983 ↗

“Methylprednisolone Sodium Succinate can reduce the disruption of the blood-brain barrier and inflammatory response in animal models of intracerebral hemorrhage, and alleviate...” NCT06921616 ↗

“Solumedrol, an anti-inflammatory glucocorticoid containing methylprednisolone sodium succinate, administered at 1 mg/kg as a premedication for anti-thymoglobulin (ATG)” NCT00186628 ↗

“This clinical study involves a perioperative pharmacological intervention using Methylprednisolone (Methylprednisolone Sodium Succinate for injection).” NCT07353749 ↗

“Participants were randomized 1:1 to the IV methylprednisolone sodium succinate (1000-mg) or oral prednisone (1250-mg) group.” PMID 29507942 ↗ Jun 2018

“Patients will be treated with injectable methylprednisolone sodium succinate as described in Arm A.” NCT06497374 ↗

“Solu - Medrol (methylprednisolone sodium succinate) 500mg IV once single administration” NCT02798068 ↗

“methylprednisolone sodium succinate equivalent to 62.5 mg of methylprednisolone” NCT05649878 ↗

Show 16 more sources

Known as Methylprednisolone sodium succinate (Solu-Medrol) “Methylprednisolone sodium succinate (Solu-Medrol)” NCT04438382 ↗
Known as Methylprednisolone succinate “Patients assigned to the corticosteroid group will receive (pulse) methylprednisolone succinate 500-1000 mg/day for 3 consecutive days followed by oral prednisolone (0.5...” NCT04662723 ↗
4

“Evaluation of the Bioavailability of Methylprednisolone Succinate Administered Intranasally” NCT05649878 ↗

“Drug: Methylprednisolone succinate 500 mg” NCT05748561 ↗

“MePRDL Methylprednisolone succinate” NCT00002565 ↗

NCT04979650 ↗

Known as Methylprednisolone, generic “Methylprednisolone, generic” NCT01809132 ↗
Known as Methylprednisolone, MP “Methylprednisolone, MP” NCT04192656 ↗
Known as Metil prednisolone “Drug: Metil prednisolone” NCT01865500 ↗